TNBIOTCGrain Mill ProductsFiscal year ends December 31

Tanke Biosciences Corp

Financials through Q3 FY2013, quarter ended Sep 30, 2013Last filing: 10-Q on Nov 14, 2013

$0.03+0.00 (0.00%)

Close on Oct 19, 2026

Community

Notes and questions about Tanke Biosciences from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Tanke Biosciences's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TNBI.

Revenue growth-19.5% · median 2.4%

Gross margin32.3% · median 31.2%

Operating margin-0.2% · median 8.9%

Net margin-7.1% · median 5.8%

Advertisement
300 × 250